I struck a chord with my recent column on H-1B visa abuse, so I’ll be following later today with an enormous post that tries to explain the underlying issues. But before then here’s something I came across that doesn’t quite fit that theme but was too interesting to let pass unnoticed — how companies like IBM intimidate employees and discourage them from speaking up.
A few years ago there was a class action lawsuit against IBM. Thirty-two thousand server administrators were being forced to work overtime without extra pay. IBM lost the suit and paid a $65 million settlement. That’s just over $2000 per affected employee before the lawyers took their share. Then IBM gave all […]

The theory of outsourcing and offshoring IT as it is practiced in the second decade of the 21st century comes down to combining two fundamental ideas: 1) that specialist firms, whether here or overseas, can provide quality IT services at lower cost by leveraging economies of scale, and; 2) that offshore labor markets can multiply that price advantage through labor arbitrage using cheaper yet just as talented foreign labor to supplant more expensive domestic workers who are in extremely short supply. While this may be true in the odd case, for the most part I believe it is a lie.
Back in April I wrote a six-part series of columns on troubles at IBM that was read by more than three million people. Months later I’m still getting ripples of response to those columns, which I followed with a couple updates. There is a very high level of pain in these responses that tells me I should do a better job of explaining the dynamics of the underlying issues not only for IBM but for IT in general in the USA. It comes down to class warfare.
So after five parts and hundreds of reader comments, what will IBM look like by the end of 2015? It will look like Oracle.
When I was growing up in Ohio, ours was the only house in the neighborhood with a laboratory. In it the previous owner, Leonard Skeggs, had invented the automated blood analyzer, pretty much creating the present biomedical industry. Unwilling to let such a facility go to waste, I threw myself into research. It was 1961 and I was eight years old.